Serum Creatinine Beneficial in Risk-Stratifying Patients With Pulmonary Embolism
Serum creatinine shows potential as a non-cardiac biomarker for assessing mortality risk among patients with pulmonary embolism.
Serum creatinine shows potential as a non-cardiac biomarker for assessing mortality risk among patients with pulmonary embolism.
In COPD, rural women continue to experience a higher burden than urban women regarding other health conditions, access to care, and poverty.
Even after treatment with inhaled corticosteroids alone or in combination with long-acting antagonists, lung function decline continues in uncontrolled asthma.
The following is a summary of "Determining the Impact of COVID-19 Infection on Patients...
The following is a summary of “Losing Your Breath During the Storm: Spontaneous Pneumothorax...
The following is a summary of "Emergent Pericardial Window in a Patient with Sarcoidosis-like...
The following is a summary of “Harnessing Artificial Intelligence for Predictive Modelling of...
The following is a summary of “Vancomycin-resistant Enterococcus (VRE) Pneumonia in a Patient...
Let us know if you'll be attending CHEST 2024 in person.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.